Position history for Fundsmith LLP's holdings in CATALYST PHARMACEUTICALS INC
Fundsmith LLP holds 844,887 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $20.9M as of 2026-Q1. The position was decreased (-74.9% shares). CPRX represents 0.2% of Fundsmith LLP's portfolio.
Current Value
$20.9M
Current Shares
844,887
Total Value Change
-$31.2M
Total Shares Change
-1.3M
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 844,887 |
-74.9% |
| $20.9M |
| 0.2% |
| $23.92 |
0 |
| 2025-Q4 | Unchanged | 3.4M | 0.0% | $78.5M | 0.5% | $23.29 | 0 |
| 2025-Q3 | Increased | 3.4M | +24.2% | $66.3M | 0.3% | $19.55 | 44 |
| 2025-Q2 | Increased | 2.7M | +25.9% | $58.8M | 0.3% | $21.78 | 44 |
| 2025-Q1 | New | 2.2M | - | $52.2M | 0.2% | $24.69 | 50 |